Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials
click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.


Alan Franciscus

Editor-in-Chief

HCV Advocate



Sunday, October 11, 2015

Drug costs a bitter pill

TALLAHASSEE

An estimated 17 percent of America’s prison population could have hepatitis C, a severe viral disease that can lead to cirrhosis, liver failure and cancer if left untreated.

There is a cure. A miracle drug with a 95 percent recovery rate was introduced in 2013. But Sovaldi has an extremely high cost: $84,000 for a standard treatment, although costs can vary with the length of the treatment.

Late last year, Gilead Sciences, which makes Sovaldi, won approval for an even better hepatitis C drug, which doesn’t have to be taken in combination with other drugs that have major side effects. But Harvoni costs about $1,125 per pill, with a standard 12-week treatment priced at $94,500

Read more....

No comments:

Post a Comment